Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of SIG: rating 5
(5 out of 5)



Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800 or 61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000SIG5
Address: 3 Myer Place, ROWVILLE, VIC, AUSTRALIA, 3178
Tel:  (03) 9215 9215Fax: (03) 9215 9188

Date first listed: 30/10/2002

Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Manufacturing, development and distribution of own branded and contract OTC (over the counter), prescription and generic pharmaceutical products for the Australian and overseas markets

News & Events

Expand this box to read and print

The suspension of trading in the securities of Sigma Healthcare Limited will be lifted immediately following the release by SIG of an announcement regarding a capital raising.


The Company announces the successful completion of the institutional component of its fully underwritten 1 for 1.85 prorata accelerated non-renounceable entitlement offer to raise approximately $400 million. The Institutional Entitlement Offer raised approximately $178 million and was strongly supported by existing eligible institutional shareholders. Take-up by existing eligible institutional shareholders under the Institutional Entitlement Offer and by HMC Capital Limited, the manager of Sigma's largest shareholder, HMC Capital Partners Fund I is 92%. The retail component of the Entitlement Offer, which is fully underwritten, will raise a further approximately $223 million. The Retail Entitlement Offer will open 9:00am (Melbourne Time) on Monday, 18 December 2023 and close 5:00pm (Melbourne Time) on Friday, 19 January 2024.


The company releases a notice of proposed issue of securities.


The Company will hold a briefing on its proposed merger and equity raise briefing at 10.30am AEDT, 11 December 2023 via webcast through this link:


The Company releases a Cleansing Notice for the underwritten pro rata accelerated non-renounceable entitlement offer.


The company lodges the following: CW Group Holdings Ltd FY21, FY22 and FY23 Audited Financial Statements.


The company releases an Investor Presentation on its Merger & Equity Raising.


Transformational merger between Sigma and CWG to create a leading healthcare wholesaler, distributor and retail pharmacy franchisor. CWG is a leading Australian retail pharmacy franchisor, supporting a multi-national Retail Network of ~600 stores, mainly operating under the highly recognised Chemist Warehouse brand. Sigma is a major Australian pharmaceutical wholesaler and pharmacy franchisor. Proposed Merger to be effected by Sigma acquiring CWG via a scheme of arrangement in exchange for Sigma shares and $700 million cash consideration. CWG shareholders to hold 85.75% and Sigma shareholders to hold 14.25% of the merged group upon completion of the Proposed Merger.


The securities of Sigma Healthcare Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SIG, pending the release of an announcement regarding a material transaction.


name changed from Sigma Pharmaceuticals Limited



Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...



    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    16/05/2022Kate Spargo120,000$0.463$55,500
    07/04/2022Christine Bartlett60,000$0.483$28,950
    30/09/2020Mark Hooper250,000$0.561$140,127
    22/09/2020Mark Hooper500,000$0.589$294,476
    19/12/2019Brian Jamieson49,604$0.568$28,150

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Vikesh RamsunderManaging Director, CEO01/02/2022
    Mark ConwayCFO01/11/2023
    Kate SpargoIndependent Director09/12/2015
    Annette CareyNon Exec Director02/02/2023
    Christopher RobertsNon Exec Director06/10/2023
    Neville MitchellNon Exec Director02/02/2023
    Michael SammellsInterim Chairman01/02/2020
    Kara McGowanCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    Christine BartlettIndependent Director30/03/201607/12/2023
    Gary WoodfordCFO01/09/202301/11/2023
    Nigel SimonszCFO29/08/202216/06/2023
    David ManuelNon Exec Director26/10/200917/05/2023
    Josephine De MartinoCFO11/04/202229/08/2022
    Ray GunstonChairman01/10/200906/07/2022
    Jeff SellsCFO01/08/201011/04/2022
    Mark HooperCEO30/08/201031/12/2021
    Jackie PearsonCFO30/09/202018/11/2021
    David BayesNon Exec Director25/06/200714/05/2021
    Wayne JohnstonCFO30/03/202026/06/2020
    Brian JamiesonNon Exec Chairman05/12/200513/05/2020
    Iona MacPhersonCFO02/11/201608/01/2020
    Linda NichollsNon Exec Director05/12/200509/12/2015
    William ScottNon Exec Director05/12/200508/06/2011
    Elmo AlwisManaging Director, CEO05/12/200513/08/2010
    John StockerNon Exec Chairman05/12/200521/06/2010
    Doug CurlewisDirector25/06/200721/06/2010
    David MortimerNon Exec Director18/11/200201/07/2007
    David DuchenNon Exec Director03/12/199916/05/2007
    Paul DuchenManaging Director06/12/2005
    Paul WilliamsExecutive06/12/2005
    Con TangalakisExecutive06/12/2005

    Date of first appointment, title may have changed.